Chen Dong, Chen Chun-Hui, Zhang Li-Lian, Lin Zhong-Ke, Zheng Jing-Wei, Phan Kevin, Mobbs Ralph J, Lin Yan, Ni Wen-Fei, Wang Xiang-Yang, Li Yan Michael, Wu Ai-Min
Department of Spine Surgery, Zhejiang Spine Surgery Centre, Orthopaedic Hospital, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University.
Statistics, Clinical Research Centre, The Eye Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
Clin Spine Surg. 2018 Jul;31(6):E310-E316. doi: 10.1097/BSD.0000000000000666.
This was a longitudinal cohort study.
The main objective of this study was to investigate the outcomes of surgery with or without radiotherapy during treatment of patients with chondrosarcoma of the osseous spine.
Chondrosarcoma is a primary spinal malignant tumor; chemotherapy and radiotherapy (RT) are generally unsuccessful, and thus, the main treatment of choice is complete en bloc resection. However, even with complete resection, these patients still have a significant rate of recurrence, morbidity, and mortality. Although there have been reports that the addition of RT to surgery may lead to increased survival and better cancer control, the evidence of the efficacy of RT remains controversial.
Patients diagnosed with chondrosarcoma who are then treated by surgery alone or surgery+RT were identified and extracted from the SEER (Surveillance, Epidemiology, and End Results) database (1973-2013). Propensity score matched (PSM) analysis was performed to balance patient characteristics between surgery alone and surgery+RT groups. Patients with a different grade and stage were stratified and analyzed.
A total of 778 patients with chondrosarcoma of the osseous spine treated by surgery alone or surgery+RT were extracted from the SEER database. Before PSM, the unadjusted Kaplan-Meier curve and bivariable Cox proportional hazard regression models showed that the surgery alone group had higher chondrosarcoma cancer-specific survival and overall survival than the surgery+RT group (both P<0.001), while the difference was attenuated after PSM. Stratified analysis found that RT was worse for low-grade chondrosarcoma patients and had a better trend for high-grade chondrosarcoma patients.
The results of our present study suggest that low-grade chondrosarcoma of the osseous spine is resistant to RT, while high-grade chondrosarcoma patients had a better trend with RT.
Level III.
这是一项纵向队列研究。
本研究的主要目的是调查在治疗脊柱骨肉瘤患者时,手术联合或不联合放疗的治疗效果。
软骨肉瘤是一种原发性脊柱恶性肿瘤;化疗和放疗(RT)通常效果不佳,因此,主要的治疗选择是整块切除。然而,即使进行了完整切除,这些患者仍有较高的复发率、发病率和死亡率。尽管有报道称手术联合放疗可能会提高生存率并更好地控制癌症,但放疗疗效的证据仍存在争议。
从监测、流行病学和最终结果(SEER)数据库(1973 - 2013年)中识别并提取诊断为软骨肉瘤且随后接受单纯手术或手术 + 放疗治疗的患者。进行倾向评分匹配(PSM)分析以平衡单纯手术组和手术 + 放疗组之间的患者特征。对不同分级和分期的患者进行分层分析。
从SEER数据库中提取了778例接受单纯手术或手术 + 放疗治疗的脊柱骨肉瘤患者。在PSM之前,未调整的Kaplan - Meier曲线和双变量Cox比例风险回归模型显示,单纯手术组的软骨肉瘤特异性生存率和总生存率高于手术 + 放疗组(均P < 0.001),而在PSM后差异减小。分层分析发现,放疗对低级别软骨肉瘤患者效果较差,对高级别软骨肉瘤患者有较好的趋势。
我们目前的研究结果表明,脊柱低级别软骨肉瘤对放疗耐药,而高级别软骨肉瘤患者接受放疗有较好的趋势。
三级。